416 related articles for article (PubMed ID: 2479178)
1. The role of interferons in the treatment of malignant neoplasms.
Murren JR; Buzaid AC
Yale J Biol Med; 1989; 62(3):271-90. PubMed ID: 2479178
[TBL] [Abstract][Full Text] [Related]
2. [Interferon in the treatment of solid tumors].
Lukac J; Seso D; Daković N; Ferencić Z; Cajkovac V; Belicza M; Soos E; Ikić D; Kusić Z
Lijec Vjesn; 1994; 116(11-12):303-7. PubMed ID: 7536287
[TBL] [Abstract][Full Text] [Related]
3. The role of interferons in the treatment of solid tumors.
Wadler S
Cancer; 1992 Aug; 70(4 Suppl):949-58. PubMed ID: 1379117
[TBL] [Abstract][Full Text] [Related]
4. [Interferons, a class of cytokines with a large therapeutic activity range].
Billard C
Bull Cancer; 1993 Sep; 80(9):741-56. PubMed ID: 7515733
[TBL] [Abstract][Full Text] [Related]
5. Gene Regulation and Clinical Roles for Interferons in Neoplastic Diseases.
Borden EC
Oncologist; 1998; 3(3):198-203. PubMed ID: 10388104
[TBL] [Abstract][Full Text] [Related]
6. The interferons.
Itri LM
Cancer; 1992 Aug; 70(4 Suppl):940-5. PubMed ID: 1379116
[TBL] [Abstract][Full Text] [Related]
7. Interferon in metastatic renal cell carcinoma.
Fosså SD
Semin Oncol; 2000 Apr; 27(2):187-93. PubMed ID: 10768597
[TBL] [Abstract][Full Text] [Related]
8. [BRM in the treatment of cancer].
Takaku F
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-3):1597-602. PubMed ID: 2454612
[TBL] [Abstract][Full Text] [Related]
9. [Biologic response modifiers in the treatment of solid tumors].
Tagliaferri F; Lucandri G; Stipa F; Stipa S
Recenti Prog Med; 1991 Jun; 82(6):352-8. PubMed ID: 1718019
[TBL] [Abstract][Full Text] [Related]
10. Biotherapy in clinical practice.
Figlin RA
Semin Hematol; 1989 Jul; 26(3 Suppl 3):15-24. PubMed ID: 2477904
[TBL] [Abstract][Full Text] [Related]
11. Biologic therapy of melanoma with cytokines and lymphocytes.
Bear HD; Hamad GG; Kostuchenko PJ
Semin Surg Oncol; 1996; 12(6):436-45. PubMed ID: 8914208
[TBL] [Abstract][Full Text] [Related]
12. Current status of interferons in the treatment of cancer.
Hansen RM; Borden EC
Oncology (Williston Park); 1992 Nov; 6(11):19-24; discussion 26, 29. PubMed ID: 1280153
[TBL] [Abstract][Full Text] [Related]
13. [Interferons in hemato-cancerology].
Boiron M
Nouv Rev Fr Hematol (1978); 1987; 29(1):49-55. PubMed ID: 2438645
[TBL] [Abstract][Full Text] [Related]
14. [The interferon system. A review of biological principles and clinical uses].
Schneider FJ
Z Gesamte Inn Med; 1986 Nov; 41(22):613-8. PubMed ID: 2436387
[TBL] [Abstract][Full Text] [Related]
15. [Interferons in the therapy of solid tumors].
Tomao S; Mozzicafreddo A; Raffaele M; Romiti A; Papò MA; Campisi C
Clin Ter; 1995; 146(8-9):491-502. PubMed ID: 8536432
[TBL] [Abstract][Full Text] [Related]
16. Redefining the role of interferon in the treatment of malignant diseases.
Bracarda S; Eggermont AM; Samuelsson J
Eur J Cancer; 2010 Jan; 46(2):284-97. PubMed ID: 19906524
[TBL] [Abstract][Full Text] [Related]
17. Biotherapy with interferon--1988.
Figlin RA
Semin Oncol; 1988 Dec; 15(6 Suppl 6):3-9. PubMed ID: 2462749
[TBL] [Abstract][Full Text] [Related]
18. [Alpha interferons--new therapeutic modalities].
Bajcetić M; Zigon N; Samardzić R; Beleslin DB
Med Pregl; 1998; 51(3-4):135-9. PubMed ID: 9611956
[TBL] [Abstract][Full Text] [Related]
19. [Clinical studies on interferon in cancer therapy in Japan].
Ohno R
Gan To Kagaku Ryoho; 1987 May; 14(5 Pt 1):1194-202. PubMed ID: 2437862
[TBL] [Abstract][Full Text] [Related]
20. Interferons in the management of viral hepatitis.
Zein NN
Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]